{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T17:29:15Z","timestamp":1790357355980,"version":"4.1.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2019,7,27]],"date-time":"2019-07-27T00:00:00Z","timestamp":1564185600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,7,27]],"date-time":"2019-07-27T00:00:00Z","timestamp":1564185600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Cardiol Rep"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1007\/s11886-019-1183-z","type":"journal-article","created":{"date-parts":[[2019,7,27]],"date-time":"2019-07-27T09:02:31Z","timestamp":1564218151000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Do Thiazide Diuretics Increase the Risk of Skin Cancer? A Critical Review of the Scientific Evidence and Updated Meta-Analysis"],"prefix":"10.1007","volume":"21","author":[{"given":"Benedetta","family":"Bendinelli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanna","family":"Masala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Garamella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domenico","family":"Palli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saverio","family":"Caini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,7,27]]},"reference":[{"issue":"1","key":"1183_CR1","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1111\/bjd.15510","volume":"177","author":"C Karimkhani","year":"2017","unstructured":"Karimkhani C, Green AC, Nijsten T, Weinstock MA, Dellavalle RP, Naghavi M, et al. The global burden of melanoma: results from the Global Burden of Disease Study 2015. Br J Dermatol. 2017;177(1):134\u201340.","journal-title":"Br J Dermatol"},{"issue":"2","key":"1183_CR2","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1002\/ijc.27616","volume":"132","author":"F Erdmann","year":"2013","unstructured":"Erdmann F, Lortet-Tieulent J, Sch\u00fcz J, Zeeb H, Greinert R, Breitbart EW, et al. International trends in the incidence of malignant melanoma 1953-2008--are recent generations at higher or lower risk? Int J Cancer. 2013;132(2):385\u2013400.","journal-title":"Int J Cancer"},{"issue":"11","key":"1183_CR3","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s11912-018-0732-8","volume":"20","author":"F Dimitriou","year":"2018","unstructured":"Dimitriou F, Krattinger R, Ramelyte E, Barysch MJ, Micaletto S, Dummer R, et al. The world of melanoma: epidemiologic, genetic, and anatomic differences of melanoma across the globe. Curr Oncol Rep. 2018;20(11):87.","journal-title":"Curr Oncol Rep"},{"issue":"1","key":"1183_CR4","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1186\/s12885-016-2963-0","volume":"16","author":"O Schoffer","year":"2016","unstructured":"Schoffer O, Sch\u00fclein S, Arand G, Arnholdt H, Baaske D, Bargou RC, et al. Tumour stage distribution and survival of malignant melanoma in Germany 2002-2011. BMC Cancer. 2016;16(1):936.","journal-title":"BMC Cancer"},{"issue":"10","key":"1183_CR5","doi-asserted-by":"publisher","first-page":"2203","DOI":"10.1002\/cam4.1152","volume":"6","author":"EAL Enninga","year":"2017","unstructured":"Enninga EAL, Moser JC, Weaver AL, Markovic SN, Brewer JD, Leontovich AA, et al. Survival of cutaneous melanoma based on sex, age, and stage in the United States, 1992-2011. Cancer Med. 2017;6(10):2203\u201312.","journal-title":"Cancer Med"},{"issue":"5","key":"1183_CR6","doi-asserted-by":"publisher","first-page":"E359","DOI":"10.1002\/ijc.29210","volume":"136","author":"J Ferlay","year":"2015","unstructured":"Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136(5):E359\u201386.","journal-title":"Int J Cancer"},{"issue":"2","key":"1183_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5826\/dpc.0702a01","volume":"7","author":"Z Apalla","year":"2017","unstructured":"Apalla Z, Lallas A, Sotiriou E, Lazaridou E, Ioannides D. Epidemiological trends in skin cancer. Dermatol Pract Concept. 2017;7(2):1\u20136.","journal-title":"Dermatol Pract Concept"},{"issue":"11","key":"1183_CR8","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1001\/jamaoncol.2018.2706","volume":"4","author":"C Fitzmaurice","year":"2018","unstructured":"Global Burden of Disease Cancer Collaboration, Fitzmaurice C, Akinyemiju TF, Al Lami FH, Alam T, Alizadeh-Navaei R, et al. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 29 cancer groups, 1990 to 2016: a systematic analysis for the global burden of disease study. JAMA Oncol. 2018;4(11):1553\u201368.","journal-title":"JAMA Oncol"},{"issue":"1","key":"1183_CR9","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.ejca.2004.10.015","volume":"41","author":"S Gandini","year":"2005","unstructured":"Gandini S, Sera F, Cattaruzza MS, Pasquini P, Abeni D, Boyle P, et al. Meta-analysis of risk factors for cutaneous melanoma: I. Common and atypical naevi. Eur J Cancer. 2005;41(1):28\u201344.","journal-title":"Eur J Cancer"},{"issue":"14","key":"1183_CR10","doi-asserted-by":"publisher","first-page":"2040","DOI":"10.1016\/j.ejca.2005.03.034","volume":"41","author":"S Gandini","year":"2005","unstructured":"Gandini S, Sera F, Cattaruzza MS, Pasquini P, Zanetti R, Masini C, et al. Meta-analysis of risk factors for cutaneous melanoma: III. Family history, actinic damage and phenotypic factors. Eur J Cancer. 2005;41(14):2040\u201359.","journal-title":"Eur J Cancer"},{"issue":"1","key":"1183_CR11","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.ejca.2004.10.016","volume":"41","author":"S Gandini","year":"2005","unstructured":"Gandini S, Sera F, Cattaruzza MS, Pasquini P, Picconi O, Boyle P, et al. Meta-analysis of risk factors for cutaneous melanoma: II. Sun exposure. Eur J Cancer. 2005;41(1):45\u201360.","journal-title":"Eur J Cancer"},{"key":"1183_CR12","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.e4757","volume":"345","author":"M Boniol","year":"2012","unstructured":"Boniol M, Autier P, Boyle P, Gandini S. Cutaneous melanoma attributable to sunbed use: systematic review and meta-analysis. BMJ. 2012;345:e4757.","journal-title":"BMJ"},{"key":"1183_CR13","unstructured":"Vitiligo Support International. Photosensitizing medication list (2017). Available online at: \n                      https:\/\/www.vitiligosupport.org\/newsletters\/fall2012\/medication.pdf"},{"key":"1183_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.critrevonc.2017.12.003","volume":"122","author":"S Gandini","year":"2018","unstructured":"\u2022 Gandini S, Palli D, Spadola G, Bendinelli B, Cocorocchio E, Stanganelli I, et al. Anti-hypertensive drugs and skin cancer risk: a review of the literature and meta-analysis. Crit Rev Oncol Hematol. 2018;122:1\u20139 This is our recent meta-analysis on the association between anti-hypertensive drugs (including thiazide diuretics) and skin cancer risk.","journal-title":"Crit Rev Oncol Hematol"},{"key":"1183_CR15","unstructured":"\u2022 European Medicines Agency (EMA). Pharmacovigilance Risk Assessment Committee (PRAC) recommendations on signals, adopted at the 3\u20136 September 218 PRAC meeting. Available online at: \n                      https:\/\/www.ema.europa.eu\/en\/documents\/prac-recommendation\/prac-recommendations-signals-adopted-3-6-september-2018-prac-meeting_en-0.pdf\n                      \n                    . This is the most recent recommendation made by the drug regulatory agency of the European Union."},{"issue":"12","key":"1183_CR16","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1039\/C8PP00011E","volume":"17","author":"S Ibbotson","year":"2018","unstructured":"\u2022 Ibbotson S. Drug and chemical induced photosensitivity from a clinical perspective. Photochem Photobiol Sci. 2018;17(12):1885\u2013903 Review of mechanisms of drug photosensitivity, with a focus on drug-induced photocarcinogenesis (the paper includes a list of drug with photosensitizing properties as well).","journal-title":"Photochem Photobiol Sci"},{"issue":"4","key":"1183_CR17","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/S1085-5629(99)80026-1","volume":"18","author":"JH Epstein","year":"1999","unstructured":"Epstein JH. Phototoxicity and photoallergy. Semin Cutan Med Surg. 1999;18(4):274\u201384.","journal-title":"Semin Cutan Med Surg"},{"key":"1183_CR18","unstructured":"\u2022 International Agency for Research on Cancer (IARC). IARC monographs on the evaluation of carcinogenic risks to humans. Volume 108: Some drugs and herbal products. 2016. Most recent judgment made by the IARC on the carcinogenetic potential of hydrochlorothiazide."},{"issue":"12","key":"1183_CR19","doi-asserted-by":"publisher","first-page":"2158","DOI":"10.1248\/bpb.b17-00561","volume":"40","author":"S Nakao","year":"2017","unstructured":"Nakao S, Hatahira H, Sasaoka S, Hasegawa S, Motooka Y, Ueda N, et al. Evaluation of drug-induced photosensitivity using the Japanese adverse drug event report (JADER) database. Biol Pharm Bull. 2017;40(12):2158\u201365.","journal-title":"Biol Pharm Bull"},{"issue":"6","key":"1183_CR20","doi-asserted-by":"publisher","first-page":"373","DOI":"10.2165\/0129784-200808060-00004","volume":"8","author":"BA Golomb","year":"2008","unstructured":"Golomb BA, Evans MA. Statin adverse effects : a review of the literature and evidence for a mitochondrial mechanism. Am J Cardiovasc Drugs. 2008;8(6):373\u2013418.","journal-title":"Am J Cardiovasc Drugs"},{"issue":"26","key":"1183_CR21","doi-asserted-by":"publisher","first-page":"e4070","DOI":"10.1097\/MD.0000000000004070","volume":"95","author":"HW Tseng","year":"2016","unstructured":"Tseng HW, Shiue YL, Tsai KW, Huang WC, Tang PL, Lam HC. Risk of skin cancer in patients with diabetes mellitus: a nationwide retrospective cohort study in Taiwan. Medicine (Baltimore). 2016;95(26):e4070.","journal-title":"Medicine (Baltimore)"},{"issue":"11","key":"1183_CR22","doi-asserted-by":"publisher","first-page":"2942","DOI":"10.1158\/1055-9965.EPI-10-0652","volume":"19","author":"J Kaae","year":"2010","unstructured":"Kaae J, Boyd HA, Hansen AV, Wulf HC, Wohlfahrt J, Melbye M. Photosensitizing medication use and risk of skin cancer. Cancer Epidemiol Biomark Prev. 2010;19(11):2942\u20139.","journal-title":"Cancer Epidemiol Biomark Prev"},{"issue":"2","key":"1183_CR23","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1016\/j.jaad.2018.06.014","volume":"80","author":"SA Pedersen","year":"2019","unstructured":"Pedersen SA, Johannesdottir Schmidt SA, H\u00f6lmich LR, Friis S, Potteg\u00e5rd A, Gaist D. Hydrochlorothiazide use and risk for Merkel cell carcinoma and malignant adnexal skin tumors: a nationwide case-control study. J Am Acad Dermatol. 2019;80(2):460\u2013465.e9.","journal-title":"J Am Acad Dermatol"},{"key":"1183_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/oxfordjournals.epirev.a036298","volume":"9","author":"S Greenland","year":"1987","unstructured":"Greenland S. Quantitative methods in the review of epidemiologic literature. Epidemiol Rev. 1987;9:1\u201330.","journal-title":"Epidemiol Rev"},{"issue":"4","key":"1183_CR25","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1002\/sim.1040","volume":"21","author":"HC van Houwelingen","year":"2002","unstructured":"van Houwelingen HC, Arends LR, Stijnen T. Advanced methods in meta-analysis: multivariate approach and meta-regression. Stat Med. 2002;21(4):589\u2013624.","journal-title":"Stat Med"},{"issue":"11","key":"1183_CR26","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1002\/sim.1186","volume":"21","author":"JP Higgins","year":"2002","unstructured":"Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21(11):1539\u201358.","journal-title":"Stat Med"},{"issue":"4","key":"1183_CR27","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.2307\/2533446","volume":"50","author":"CB Begg","year":"1994","unstructured":"Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994;50(4):1088\u2013101.","journal-title":"Biometrics"},{"issue":"9","key":"1183_CR28","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1038\/bjc.1996.216","volume":"73","author":"J Westerdahl","year":"1996","unstructured":"Westerdahl J, Olsson H, M\u00e5sb\u00e4ck A, Ingvar C, Jonsson N. Risk of malignant melanoma in relation to drug intake, alcohol, smoking and hormonal factors. Br J Cancer. 1996;73(9):1126\u201331.","journal-title":"Br J Cancer"},{"issue":"13","key":"1183_CR29","doi-asserted-by":"publisher","first-page":"2467","DOI":"10.1016\/j.ejca.2010.04.024","volume":"46","author":"R Ruiter","year":"2010","unstructured":"Ruiter R, Visser LE, Eijgelsheim M, Rodenburg EM, Hofman A, Coebergh JW, et al. High-ceiling diuretics are associated with an increased risk of basal cell carcinoma in a population-based follow-up study. Eur J Cancer. 2010;46(13):2467\u201372.","journal-title":"Eur J Cancer"},{"issue":"Suppl 2","key":"1183_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1365-2133.2012.11081.x","volume":"167","author":"E de Vries","year":"2012","unstructured":"de Vries E, Trakatelli M, Kalabalikis D, Ferrandiz L, Ruiz-de-Casas A, Moreno-Ramirez D, et al. Known and potential new risk factors for skin cancer in European populations: a multicentre case-control study. Br J Dermatol. 2012;167(Suppl 2):1\u201313.","journal-title":"Br J Dermatol"},{"issue":"16","key":"1183_CR31","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1001\/archinternmed.2012.2754","volume":"172","author":"GD Friedman","year":"2012","unstructured":"Friedman GD, Asgari MM, Warton EM, Chan J, Habel LA. Antihypertensive drugs and lip cancer in non-Hispanic whites. Arch Intern Med. 2012;172(16):1246\u201351.","journal-title":"Arch Intern Med"},{"issue":"8","key":"1183_CR32","doi-asserted-by":"publisher","first-page":"1950","DOI":"10.1038\/jid.2013.33","volume":"133","author":"SN Robinson","year":"2013","unstructured":"Robinson SN, Zens MS, Perry AE, Spencer SK, Duell EJ, Karagas MR. Photosensitizing agents and the risk of non-melanoma skin cancer: a population-based case-control study. J Invest Dermatol. 2013;133(8):1950\u20135.","journal-title":"J Invest Dermatol"},{"issue":"3","key":"1183_CR33","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1007\/s40264-016-0487-9","volume":"40","author":"B Nardone","year":"2017","unstructured":"Nardone B, Majewski S, Kim AS, Kiguradze T, Martinez-Escala EM, Friedland R, et al. Melanoma and non-melanoma skin cancer associated with angiotensin-converting-enzyme inhibitors, angiotensin-receptor blockers and thiazides: a matched cohort study. Drug Saf. 2017;40(3):249\u201355.","journal-title":"Drug Saf"},{"issue":"4","key":"1183_CR34","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1111\/joim.12629","volume":"282","author":"A Potteg\u00e5rd","year":"2017","unstructured":"Potteg\u00e5rd A, Hallas J, Olesen M, Svendsen MT, Habel LA, Friedman GD, et al. Hydrochlorothiazide use is strongly associated with risk of lip cancer. J Intern Med. 2017;282(4):322\u201331.","journal-title":"J Intern Med"},{"issue":"4","key":"1183_CR35","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/j.jaad.2017.11.042","volume":"78","author":"SA Pedersen","year":"2018","unstructured":"Pedersen SA, Gaist D, Schmidt SAJ, H\u00f6lmich LR, Friis S, Potteg\u00e5rd A. Hydrochlorothiazide use and risk of nonmelanoma skin cancer: a nationwide case-control study from Denmark. J Am Acad Dermatol. 2018;78(4):673\u2013681.e9.","journal-title":"J Am Acad Dermatol"},{"issue":"8","key":"1183_CR36","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1001\/jamainternmed.2018.1652","volume":"178","author":"A Potteg\u00e5rd","year":"2018","unstructured":"Potteg\u00e5rd A, Pedersen SA, Schmidt SAJ, H\u00f6lmich LR, Friis S, Gaist D. Association of hydrochlorothiazide use and risk of malignant melanoma. JAMA Intern Med. 2018;178(8):1120\u20132.","journal-title":"JAMA Intern Med"},{"key":"1183_CR37","first-page":"S1","volume":"5","author":"FM Shaw","year":"2018","unstructured":"Shaw FM, Li W, Winstock MA. Antihypertensive medications and risk of keratinocyte carcinoma. J Invest Dermatol. 2018;5:S1\u2013S296.","journal-title":"J Invest Dermatol"},{"issue":"8","key":"1183_CR38","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1111\/jdv.12921","volume":"29","author":"SA Schmidt","year":"2015","unstructured":"Schmidt SA, Schmidt M, Mehnert F, Lemeshow S, S\u00f8rensen HT. Use of antihypertensive drugs and risk of skin cancer. J Eur Acad Dermatol Venereol. 2015;29(8):1545\u201354.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"10","key":"1183_CR39","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1001\/jamainternmed.2018.4312","volume":"178","author":"BH van den Born","year":"2018","unstructured":"van den Born BH, Olde-Engberink R, Vogt L. Hydrochlorothiazide and the risk of malignant melanoma. JAMA Intern Med. 2018;178(10):1425.","journal-title":"JAMA Intern Med"},{"issue":"7","key":"1183_CR40","doi-asserted-by":"publisher","first-page":"1855","DOI":"10.1038\/bjc.2014.43","volume":"110","author":"S Wu","year":"2014","unstructured":"Wu S, Han J, Vleugels RA, Puett R, Laden F, Hunter DJ, et al. Cumulative ultraviolet radiation flux in adulthood and risk of incident skin cancers in women. Br J Cancer. 2014;110(7):1855\u201361.","journal-title":"Br J Cancer"},{"issue":"1","key":"1183_CR41","doi-asserted-by":"publisher","first-page":"27","DOI":"10.2188\/jea.JE20160166","volume":"28","author":"I Savoye","year":"2018","unstructured":"Savoye I, Olsen CM, Whiteman DC, Bijon A, Wald L, Dartois L, et al. M. Patterns of ultraviolet radiation exposure and skin cancer risk: the E3N-SunExp study. J Epidemiol. 2018;28(1):27\u201333.","journal-title":"J Epidemiol"},{"issue":"10159","key":"1183_CR42","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.1016\/S0140-6736(18)32225-6","volume":"392","author":"GBD 2017","year":"2018","unstructured":"GBD 2017. Risk Factor Collaborators. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990\u20132017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392(10159):1923\u201394.","journal-title":"Lancet"},{"issue":"4","key":"1183_CR43","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1038\/s41371-019-0190-2","volume":"33","author":"L Faconti","year":"2019","unstructured":"\u2022 Faconti L, Ferro A, Webb AJ, Cruickshank JK, Chowienczyk PJ, British and Irish Hypertension Society. Hydrochlorothiazide and the risk of skin cancer. A scientific statement of the British and Irish Hypertension Society. J Hum Hypertens. 2019;33(4):257\u20138 Recommendation on whether hydrochlorothiazide should be (1) considered to start treating patients newly diagnosed with hypertension, or (2) discontinued for patients already using it.","journal-title":"J Hum Hypertens"}],"container-title":["Current Cardiology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11886-019-1183-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11886-019-1183-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11886-019-1183-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,25]],"date-time":"2020-07-25T23:10:43Z","timestamp":1595718643000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11886-019-1183-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,27]]},"references-count":43,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["1183"],"URL":"https:\/\/doi.org\/10.1007\/s11886-019-1183-z","relation":{},"ISSN":["1523-3782","1534-3170"],"issn-type":[{"value":"1523-3782","type":"print"},{"value":"1534-3170","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,27]]},"assertion":[{"value":"27 July 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Benedetta Bendinelli, Giovanna Masala, Giuseppe Garamella, Domenico Palli, and Saverio Caini declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}],"article-number":"92"}}